Tadashi Terada Selected Research

Tadashi Terada Research Topics

Disease

93	Neoplasms (Cancer) 10/2020 - 06/2002
25	Carcinoma (Carcinomatosis) 01/2014 - 11/2003
20	Adenocarcinoma 01/2013 - 07/2005
10	Neoplasm Metastasis (Metastasis) 01/2015 - 05/2003
8	Small Cell Carcinoma 01/2015 - 04/2009
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2013 - 04/2009
6	Signet Ring Cell Carcinoma 01/2013 - 02/2009
5	Cysts 01/2013 - 10/2003
4	Ulcer 01/2013 - 03/2011
3	Amyloidosis 08/2015 - 11/2009
3	Metaplasia 01/2013 - 09/2010
3	Melanoma (Melanoma, Malignant) 01/2012 - 10/2010
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2012 - 10/2010
3	Carcinoid Tumor (Carcinoid) 01/2012 - 11/2010
2	Clear Cell Adenocarcinoma 09/2014 - 03/2011
2	Polyps 01/2013 - 03/2011
2	Adenoma (Adenomas) 01/2013 - 03/2011
2	Cholangiocarcinoma 01/2013 - 06/2002
2	Myoepithelioma 01/2013 - 02/2011
2	Neuroblastoma 01/2012 - 04/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2012 - 10/2011
2	Sarcoma (Soft Tissue Sarcoma) 06/2011 - 02/2010
2	Pancreatitis 03/2011 - 11/2002
2	Granular Cell Tumor 10/2010 - 04/2009
2	Hepatocellular Carcinoma (Hepatoma) 10/2010 - 11/2002
2	Transitional Cell Carcinoma 06/2010 - 11/2009
1	Immunoglobulin Light-chain Amyloidosis 08/2015
1	Glioblastoma (Glioblastoma Multiforme) 07/2015
1	Adenomyoma 02/2015

Drug/Important Bio-Agent (IBA)

48	VimentinIBA 02/2015 - 01/2008
39	Keratins (Keratin)IBA 07/2015 - 01/2008
38	SynaptophysinIBA 01/2015 - 11/2002
38	Proteins (Proteins, Gene)FDA Link 01/2015 - 06/2002
34	S100 Proteins (S 100 Protein)IBA 10/2014 - 01/2008
29	ChromograninsIBA 01/2015 - 01/2009
27	Phosphopyruvate Hydratase (Enolase)IBA 01/2015 - 01/2009
26	CAM 5.2 antigenIBA 02/2015 - 01/2011
25	AntigensIBA 03/2015 - 02/2004
24	DesminIBA 10/2014 - 12/2008
16	ElementsIBA 01/2013 - 02/2009
15	Mucin-1 (CA 15-3 Antigen)IBA 05/2014 - 11/2003
15	MucinsIBA 01/2013 - 08/2003
11	MyoglobinIBA 10/2014 - 11/2009
9	Ki-67 Antigen (Ki 67 Antigen)IBA 01/2013 - 01/2009
8	von Willebrand FactorIBA 01/2013 - 01/2009
8	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2012 - 01/2009
6	Platelet-Derived Growth FactorIBA 01/2015 - 01/2011
6	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 10/2014 - 01/2012
6	Carcinoembryonic AntigenIBA 07/2013 - 11/2002
5	Progesterone Receptors (Progesterone Receptor)IBA 03/2011 - 12/2008
5	Estrogen ReceptorsIBA 03/2011 - 12/2008
5	Capsules (Microcapsules)IBA 12/2010 - 05/2003
4	Fetal Proteins (Fetoprotein)IBA 04/2012 - 10/2010
4	CarbohydratesIBA 04/2011 - 02/2004
3	Coloring Agents (Dyes)IBA 08/2015 - 11/2009
3	Congo RedIBA 08/2015 - 11/2009
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2015 - 09/2011
3	GlycogenIBA 09/2014 - 03/2011
3	Calbindin 2IBA 05/2014 - 12/2010
3	Immunoglobulin G (IgG)IBA 02/2012 - 11/2009
3	Immunoglobulin A (IgA)IBA 02/2012 - 11/2009
3	Immunoglobulin M (IgM)IBA 02/2012 - 11/2009
3	Glial Fibrillary Acidic ProteinIBA 01/2012 - 11/2009
3	Glucagon (Glukagon)FDA Link 11/2010 - 02/2009
2	Keratin-5 (Keratin 5)IBA 10/2020 - 12/2010
2	Eosine Yellowish-(YS) (Eosin)IBA 10/2014 - 10/2010
2	Hematoxylin (Haematoxylon)IBA 10/2014 - 10/2010
2	Serotonin (5 Hydroxytryptamine)IBA 05/2014 - 11/2010
2	B72.3 antibodyIBA 05/2014 - 12/2010
2	Chromogranin AIBA 03/2013 - 11/2011
2	CholesterolIBA 01/2013 - 10/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2013 - 01/2012
2	GalliumIBA 01/2013 - 03/2011
2	Melanins (Melanin)IBA 10/2012 - 01/2012
2	Cyclin D1IBA 02/2012 - 11/2002
2	Apoprotein(a) (Apolipoprotein (a))IBA 01/2012 - 12/2011
2	Surface-Active Agents (Surfactants)IBA 01/2012 - 12/2011
2	Codon (Codons)IBA 10/2011 - 01/2009
2	ParaffinIBA 10/2011 - 10/2010
2	Amylases FDA Link 03/2011 - 01/2009
2	CD34 Antigens (CD34 Antigen)IBA 03/2011 - 01/2009
2	Calmodulin-Binding Proteins (Caldesmon)IBA 02/2011 - 12/2010
2	Cisplatin (Platino)FDA LinkGeneric 01/2011 - 01/2010
2	GastrinsIBA 11/2010 - 12/2009
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2010 - 12/2009
2	Keratin-7 (Cytokeratin 7)IBA 11/2010 - 09/2010
2	BilirubinIBA 05/2010 - 08/2003
2	Lipase (Acid Lipase)FDA Link 01/2009 - 02/2004

Therapy/Procedure

13	Drug Therapy (Chemotherapy) 01/2015 - 07/2008
5	Salpingo-oophorectomy 07/2012 - 07/2005
4	Nephrectomy 01/2014 - 01/2010
4	Hysterectomy 01/2013 - 07/2005
3	Cholecystectomy 01/2013 - 11/2003
3	Oral Diagnosis (Oral Examination) 01/2012 - 09/2011
3	Laparotomy 06/2011 - 07/2008
2	Prostatectomy (Retropubic Prostatectomy) 07/2012 - 01/2011
2	Cystectomy 01/2012 - 11/2009
2	Appendectomy 08/2009 - 04/2009
2	Therapeutics 04/2009 - 05/2003
1	Uterine Myomectomy 02/2015